Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$34.5 - $42.19 $5.01 Million - $6.13 Million
-145,233 Reduced 55.71%
115,463 $4.87 Million
Q1 2023

May 15, 2023

BUY
$33.32 - $40.98 $7.03 Million - $8.65 Million
211,044 Added 425.05%
260,696 $9.29 Million
Q4 2022

Feb 14, 2023

BUY
$25.32 - $51.45 $1.26 Million - $2.55 Million
49,652 New
49,652 $1.82 Million
Q1 2019

May 15, 2019

SELL
$36.91 - $55.7 $1.05 Million - $1.58 Million
-28,451 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$36.49 - $51.72 $4.29 Million - $6.08 Million
-117,528 Reduced 80.51%
28,451 $1.12 Million
Q3 2018

Nov 14, 2018

BUY
$46.5 - $53.55 $1.87 Million - $2.16 Million
40,279 Added 38.11%
145,979 $7.53 Million
Q2 2018

Aug 14, 2018

SELL
$35.0 - $48.9 $8.54 Million - $11.9 Million
-243,979 Reduced 69.77%
105,700 $4.96 Million
Q1 2018

May 15, 2018

BUY
$31.7 - $44.1 $11.1 Million - $15.4 Million
349,679 New
349,679 $12.4 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.